This report is based on data for 2018-2020 retrieved on 13 February 2023 from The European Surveillance System (TESSy) and ECDC’s decentralised data storage for antimicrobial resistance and healthcare-associated infections (ARHAI). TESSy is a system for the collection, analysis and dissemination of data on communicable diseases.
This document presents the estimated incidence of bloodstream infections (BSI) with three key antibiotic-resistant bacteria, at country level in EU/EEA countries, using public data sources.
The results presented in this report are based on antimicrobial resistance (AMR) data from invasive isolates reported to the Central Asian and European surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2022 (data referring to 2021).
The second “Surveillance of antimicrobial resistance in Europe” report, published jointly by the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe on 14 April 2023, shows high percentages of resistance to last-line antibiotics, such as carbapenems, in several countries of the WHO European Region. The report features data from 2021.
Reporting protocol for submitting data on antimicrobial resistance to ECDC, through the European Antimicrobial Resistance Surveillance Network (EARS-Net).
Resistance of Salmonella and Campylobacter to commonly used antimicrobials is frequently observed in humans and animals, reveals a report by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
This report provides an overview of the main findings of the 2020–2021 harmonised AMR monitoring in Salmonella spp., Campylobacter jejuni and C. coli in humans and food-producing animals and relevant meat thereof.
The overall aim of the protocol is to support the implementation of a PPS of HAIs and antimicrobial use in European long-term care facilities, to meet the abovementioned objectives for ECDC surveillance.